Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Qiagen's COVID-19 PCR Tests Remain Accurate in Detecting South African Variant; Shares Rise Early

11/26/2021 | 09:56am EST


© MT Newswires 2021
All news about QIAGEN N.V.
01/21QIAGEN N : Earnings Document
PU
01/19Qiagen N.V Launched Higher on M&A Chatter
MT
01/19QIAGEN N : supports young biotechnology and pharma companies by announcing winners of firs..
PU
01/19QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
BU
01/18QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
BU
01/18QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
CI
01/18DZ Bank Upgrades Qiagen to Buy from Hold, Raises Price Target to $59.34 From $55.79
MT
01/17ANALYST RECOMMENDATIONS : Admiral, Hiscox, National Grid, Qiagen, Unilever...
01/17QIAGEN NV : DZ Bank takes a positive view
MD
01/13QIAGEN N : liquid-based sample-prep-and-detection kit helps labs ramp up COVID testing cap..
PU
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2021 2 198 M - -
Net income 2021 473 M - -
Net Debt 2021 941 M - -
P/E ratio 2021 23,3x
Yield 2021 -
Capitalization 11 054 M 11 054 M -
EV / Sales 2021 5,46x
EV / Sales 2022 5,62x
Nbr of Employees 6 000
Free-Float 97,8%
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 48,69 $
Average target price 57,79 $
Spread / Average Target 18,7%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Vice President-Finance
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-10.81%11 054
MODERNA, INC.-36.98%64 900
LONZA GROUP AG-15.65%52 307
IQVIA HOLDINGS INC.-14.60%46 031
SEAGEN INC.-17.50%23 323
ICON PUBLIC LIMITED COMPANY-18.65%20 508